Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
Teva's drug pipeline could contain blockbusters - Globes
Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry | IntechOpen
EX-99.1
SymBio Pharmaceuticals : Pipeline : Treakisym® SyB L-0501
Teva-Takeda joint venture divests certain assets in Japan to Nichi-Iko - Pharmaceutical Technology
Sosei see Teva pipeline cull as an opportunity -
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
Celltrion FDA warning causes headache for Teva's biologics ambition
EX-99.1
FDA nods for Teva, J&J signal pipeline progress - MM+M - Medical Marketing and Media
Teva's (TEVA) NDA for Schizophrenia Drug Gets FDA Acceptance
Israel's Teva on FDA blacklist of drugmakers creating barriers to competition | The Times of Israel
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
Fresh from the biotech pipeline—2012 | Nature Biotechnology
Teva expects FDA preapproval inspection of troubled Celltrion plant this year | FiercePharma
A Look at Teva's Generic Drugs Research Pipeline
The Teva Advantage
FDA approves first generic version of epilepsy drug Sabril from Teva
Refreshing the biologic pipeline 2020 | Nature Biotechnology
EX-99.1
Teva Pharmaceuticals Near 20-Year Lows (NYSE:TEVA) | Seeking Alpha
Producing Quality Products | Teva Pharmaceuticals
